in early trading today, A-Shares continued to fluctuate slightly. The Shanghai stock index opened low and went low for a time, down nearly 1%. The performance of science and technology stocks was relatively active. The gem index and Kechuang 50 both opened low and went high and went slightly red.
On the disk, the overall performance of the pharmaceutical sector led by covid-19 detection and traditional Chinese medicine was strong, the concept of prefabricated dishes was also strong, and the decline of coal, oil, banking, tourism and other sectors was the top. The net inflow of funds going north was 1.816 billion yuan.
the first share of baseband chip broke the market
today's A-share is another moment to witness history. Aojie technology, known as the first share of baseband chip, officially landed on the science and innovation board today. At the opening, it fell 20.99% lower than the issue price, and then continued to decline, with a minimum drop of more than 34%, setting a new record of breaking new shares on the first day in more than 20 years. At the highest time, each successful investor lost more than 28000 yuan, which is also a record of loss on the first day of innovation shares.
The issuing price of Aojie technology is as high as 164.54 yuan. The magic thing is that according to the statistics of wind data, Aojie technology has never made a profit or made a huge loss in the new year, and the trend of loss is still endless. According to the prospectus, Aojie technology itself predicts that it will still have a net loss of 549-607 million yuan in 2021. according to the latest three quarterly reports before the issuance, Aojie technology's net assets per share are only about 3.3 yuan, and the issuance price exceeds the net assets per share by nearly 50 times, which is also very rare in the A-share market.
This overestimation is largely due to the concept of company scarcity. Aojie technology is not only the first baseband company listed in a shares, but also a global scarce baseband chip manufacturer. The chip concept is already popular. It seems expensive to add the current global "lack of core tide".
But does making chips necessarily represent high technology? According to the prospectus, Aojie technology made it clear that the company's mobile phone baseband chip is only used for functional machines and has not yet formed the revenue of smart phone baseband chip. Isn't it a little confused? The function machine is dusty in most people's memory. Even many people after 00 and 10 don't know what the function machine is. Aojie technology also expects that it will take 3 to 5 years for the company's new generation of smart phone chip products from project initiation to product design, mass production and commercialization. According to Moore's law, the chip needs to be updated and iterated once in 18 months. It can be upgraded several times in 3 to 5 years. How much commercial value will it have when it is developed.
What's more, Aojie technology also said that the company still needs to invest a lot of R & D expenses in the R & D and accumulation of smartphone chip related technologies. There is uncertainty about the success of product R & D and the risk of failure in the R & D of the company's smartphone chip.
Today's break was not only Aojie technology, Jl Mag Rare-Earth Co.Ltd(300748) H shares were officially listed on the Hong Kong stock exchange, and they also broke sharply at the opening, with the lowest price falling by more than 17% compared with the issue price, and Jl Mag Rare-Earth Co.Ltd(300748) A shares once opened low and fell by nearly 3% in the morning.
covid-19 detection concept continues to soar
The covid-19 detection concept continued to soar in the morning. As of the noon closing, the volume of the sector index rose by 2.86%, and the leading Andon Health Co.Ltd(002432) rose the limit again. Recently, it has risen the limit for four consecutive times, and a total of 27 trading plates have been harvested in the past two months, with a cumulative rise of nearly 12 times in a short time; Hangzhou Alltest Biotech Co.Ltd(688606) 20% limit, Zhejiang Orient Gene Biotech Co.Ltd(688298) , Asahi biology, Changzhou Qianhong Biopharma Co.Ltd(002550) etc. limit or exceed 10%.
Recently, the repeated epidemic situation has led to a surge in the demand for covid-19 testing in the United States. On Thursday (January 13), local time, U.S. President Biden said he would instruct the U.S. government to purchase an additional 500 million covid-19 testing kits to help meet the needs of all parts of the United States during the spread of Omicron mutant virus, At the same time, the most protective N95 mask will be provided free of charge. Prior to this, the U.S. government has planned to purchase 500 million covid-19 test kits.
Andon Health Co.Ltd(002432) it was announced early this morning that the U.S. subsidiary and ACC signed a purchase contract on January 13, 2022 local time to sell ihealth kit products. The total contract price tax is $1.275 billion (including freight), about 8.1 billion yuan, which has exceeded 50% of the company's audited main business income in 2020. Andon Health Co.Ltd(002432) said that the performance of the contract will have a positive impact on the company's operating revenue and operating profit in 2022. The company will recognize the revenue in the corresponding accounting period according to the performance of the contract and the revenue recognition principle, and the recognition of relevant financial data shall be subject to the audited financial report.
According to CNBC's latest report, from January 2022, the Biden government will distribute home rapid testing kits to Americans free of charge. The plan will be underwritten by insurance companies. From January 15, private health insurance companies will be required to pay 8 home covid-19 tests per month for the people in their plan. According to the new policy, Americans can buy family testing reagents free of charge under insurance, or submit testing receipts for reimbursement. The maximum reimbursement amount is the monthly limit per person. For example, a family of four can reimburse up to 32 inspections per month.
At present, the population of the United States is about 330 million. If the insurance company pays 8 times a month, the monthly demand of the U.S. government to distribute kits to the public free of charge is about 2.6 billion rapid detection kits. At present, the 1 billion rapid detection kits purchased by the U.S. government are far from enough.
China is the main supplier of covid-19 rapid self-test kit in the world. According to China's customs data, China's covid-19 antigen reagent was mainly sold to Germany, the United Kingdom, the United States, Canada and Greece in November 2021. Among them, Germany imported 1.308 billion yuan in November, an increase of 179.24% month on month. The import volume of Britain and the United States ranked second and third, reaching 715 million yuan and 346 million yuan respectively, with a month on month increase of 27.58% and 179.24% respectively.
However, in the face of huge market potential, investors should also remain calm. At the peak of covid-19 in 2020, Kingfa Sci.& Tech.Co.Ltd(600143) also received a purchase order for kn95 masks of US $975 million (about RMB 6.8 billion) from the United States. At that time, it was also envious of many Chinese mask manufacturers, and the share price of Kingfa Sci.& Tech.Co.Ltd(600143) also soared for a time. However, only three months later, the epidemic situation improved, and the order was completely announced to have failed. The reason is that Kingfa Sci.& Tech.Co.Ltd(600143) has not received the advance payment from the American buyer, and finally the official announcement that the contract has actually been terminated. Therefore, the huge order of Andon Health Co.Ltd(002432) also depends on the subsequent specific implementation.
Fight Omicron! Biden purchased 500 million additional test kits and distributed N95 masks free of charge
After the covid-19 detection concept was reshuffled, there was withdrawal and counter attack in the epidemic era
Andon Health Co.Ltd(002432) : the U.S. subsidiary signed major contracts for daily operation, with an amount of about 8.1 billion yuan
Covid-19 testing concept stocks rose sharply: at least 10 domestic rapid testing products were approved in Europe and America
